Brief: Aeterna Zentaris Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule
26/01/2021 21:39
Jan 26 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS GRANTED 180-DAY EXTENSION BY NASDAQ TO
REGAIN
COMPLIANCE WITH MINIMUM BID PRICE RULE
Source text for Eikon: ID:nGNX2RB48
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update